Aptorum Group Ltd Cl A (APM) |
|
3.48 0.01 (0.29%)
|
08-13 15:59 |
|
Open: |
3.43 |
Pre. Close: |
3.47 |
|
High:
|
3.59 |
Low:
|
3.43 |
|
Volume:
|
48,263 |
Market Cap:
|
106M |
|
|
|
|
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited has a research and development agreement with Covar Pharmaceuticals to investigate 3 repurposed drug candidates (SACT-COV19) for coronavirus disease under existing Smart-ACT platform and Acticule infectious disease platform. Aptorum Group Limited was incorporated in 2010 and is headquartered in Hong Kong, Hong Kong. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.595 - 3.615 |
3.615 - 3.634 |
|
Low:
|
3.378 - 3.404 |
3.404 - 3.427 |
|
Close:
|
3.443 - 3.48 |
3.48 - 3.514 |
|
Technical analysis |
as of: 2020-08-13 4:31:36 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.49 One year: 5.09 |
| Support: |
Support1: 3.00 Support2: 2.50 |
| Resistance: |
Resistance1: 3.84 Resistance2: 4.36 |
| Pivot: |
3.61  |
| Moving Average: |
MA(5): 3.53 MA(20): 3.62 
MA(100): 3.44 MA(250): 9.78 |
| MACD: |
MACD(12,26): -0.02 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 20.72 %D(3): 25.93 |
| RSI: |
RSI(14): 46.11 |
| 52-week: |
High: 18.25 Low: 1.66 Change(%): -78.6 |
| Average Vol(K): |
3-Month: 11422 10-Days: 6937 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.APM has closed above bottom band by 23.3%. Bollinger Bands are 55.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to APM's normal range. The bands have been in this narrow range for 96 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 27 Jul 2020
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM - Business News Asia
Fri, 17 Jul 2020
Aptorum Group Prospectus Receives Approval for Listing on the Euronext Paris Stock Exchange - Watertown Public Opinion
Fri, 17 Jul 2020
Does the Market Like Aptorum Group Ltd (APM) Stock After it Is Higher By 10.37% in a Week? - InvestorsObserver
Thu, 25 Jun 2020
Analysts Recommend Catching These 2 Falling Knives - Yahoo Finance
Mon, 15 Jun 2020
Aptorum Group Limited Strengthens Its Presence in the US With the Appointment of Dr. Kira Sheinerman - Business Wire
Mon, 18 May 2020
Aptorum Group to Hold Investor Webinar and Q&A Session with President on May 19 - Business Wire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
8 |
| Shares Float (M) |
5 |
|
% Held by Insiders
|
37.66 |
|
% Held by Institutions
|
0.01 |
|
Shares Short (K)
|
30 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.644 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.560 |
|
Profit Margin
|
|
|
Operating Margin
|
-3400.52 |
|
Return on Assets (ttm)
|
-33.0 |
|
Return on Equity (ttm)
|
-84.5 |
|
Qtrly Rev. Growth
|
-17.2 |
|
Gross Profit (p.s.)
|
-0.033 |
|
Sales Per Share
|
0.067 |
|
EBITDA (p.s.)
|
-2.126 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
3 |
Stock Valuations |
|
PE Ratio
|
-5.40 |
|
PEG Ratio
|
|
|
Price to Book value
|
6.21 |
|
Price to Sales
|
51.69 |
|
Price to Cash Flow
|
-2.07 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
